RLMD
Relmada Therapeutics, Inc. · Healthcare
CFO Maged Shenouda sold $112K of Relmada Therapeutics, Inc.
Sold$112,134
$35.04Price
3,200Shares
−59%Stake
What RLMD did after the filing
- The stock from Thu, Feb 4 close, $33.81
- +8.2%
- S&P 500, same days
- +1.2%
Measured over 30 trading days, to the Mar 19 close.
Traded Tue, Feb 2. Filed Thu, Feb 4, 12:38 PM ET, during the session. Returns use the Feb 4 close and the Mar 19 close. Not investment advice.